A 4-week Dose-Ranging, Dose-Interval, Efficacy, Safety and Tolerability Study of GSK961081 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT01319019 · COMPLETED
Trial details
- NCT number
- NCT01319019
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2011-09-01
- Enrollment
- 437
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.